ConductScience.org, home

Gene · 8744

Papers3,166

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

421 to 440 of 3,166

Download this page as JSON
TitleJournalYearPMIDFound bySource
Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes.Cells202337371066PubTator, text miningPubMed
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives.Curr Oncol202337366915PubTator, text miningPubMed
4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell.Cell Mol Immunol202337365325PubTator, text miningPubMed
CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation.J Immunother Cancer202337364935PubTator, text miningPubMed
Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses.Cell Rep202337355988PubTator, text miningPubMed
An integrated bioinformatic investigation of focal adhesion-related genes in glioma followed by preliminary validation of COL1A2 in tumorigenesis.Aging (Albany NY)202337354488PubTator, text miningPubMed
Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP.BMC Immunol202337353774PubTator, text miningPubMed
Modelling viral encephalitis caused by herpes simplex virus 1 infection in cerebral organoids.Nat Microbiol202337349587PubTator, text miningPubMed
Cis Interactions of Membrane Receptors and Ligands.Annu Rev Cell Dev Biol202337339682PubTator, text miningPubMed
Potential role of human umbilical cord stem cells-derived exosomes as novel molecular inhibitors of hepatocellular carcinoma growth.Apoptosis202337338718PubTator, text miningPubMed
Targeting GITR in cancer immunotherapy - there is no perfect knowledge.Oncotarget202337335294PubTator, text miningPubMed
Targeting CD137 (4-1BB) towards improved safety and efficacy for cancer immunotherapy.Front Immunol202337334375PubTator, text miningPubMed
An amino acid metabolism-based seventeen-gene signature correlates with the clinical outcome and immune features in pancreatic cancer.Front Genet202337333498PubTator, text miningPubMed
T cells in health and disease.Signal Transduct Target Ther202337332039PubTator, text miningPubMed
Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?Curr Treat Options Oncol202337318724PubTator, text miningPubMed
Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.Cancer Immunol Immunother202337310433PubTator, text miningPubMed
Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy.Transl Cancer Res202337304539PubTator, text miningPubMed
Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures.Front Immunol202337304291PubTator, text miningPubMed
Special Issue "New Developments in Natural Killer Cells for Immunotherapy".Cells202337296617PubTator, text miningPubMed
IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities.Front Immunol202337287982PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/8744/papers?page=22